Originally published on Mon November 11, 2013 6:36 am
In the hunt for new ways to help people fight alcoholism, doctors are studying gabapentin, a generic drug that's commonly used to treat epilepsy and fibromyalgia.
In a 12-week clinical trial conducted by the Scripps Research Institute, people taking taking gabapentin were much better at reducing their alcohol intake than those who got a placebo. The research, involving 150 people, was funded by the National Institutes of Health.
Originally published on Thu November 7, 2013 12:58 pm
Voters appear to have defeated another attempt to require labels on genetically modified foods in Washington state. In early counts, the "no" campaign has what appears to be an insurmountable lead with 54 percent of votes.
The ballot initiative would require labels on the front of packages for most food products, seeds and commodities like soy or corn if they were produced using genetic engineering.
The New York Stock Exchange is at the center of attention Thursday morning as Twitter goes public at $26 per share. That means company is expected to raise almost $2 billion. For the latest on this highly anticipated IPO, NPR's Zoe Chace talks with host David Greene.
Originally published on Thu November 7, 2013 5:43 pm
6 p.m. ET: Twitter Shares Close At $44.90
At the end of its first day of public trading, shares of Twitter were valued at $44.90, reflecting a market value of more than $31 billion. The company sold 70 million shares of stock, raising $1.82 billion in the process.
Earlier Thursday, the company's shares soared from their initial public offering price of $26.
2:35 p.m. ET:
As you can see if you click on the player below, Twitter's stock has been trading around $47 a share in recent minutes.
Originally published on Thu November 7, 2013 5:15 am
In the essay "The Myth of Sisyphus," philosopher Albert Camus — who would have turned 100 on Thursday — explored the nature of boring work. There's new psychological research into why people end up in boring jobs.
The new health care law will provide around $1 trillion in subsidies to low- and middle-income Americans over the next decade to help them pay for health insurance.
Johanna Humbert of Galien, Mich., was pleasantly surprised to discover that she qualifies for an insurance subsidy, since her current plan is being canceled. Humbert makes about $30,000 a year, so she'll get a subsidy of about $300 a month. The new plan is similar to her current one, but it will cost $250 — about half of what she pays now.
But where will the money come from to pay for subsidies like these?